泌尿器科領域に於ける17-Ketosteroidの研究補遺 第III篇:各種疾患並びにホルモン剤投与時に於ける尿中17-Ketosteroidの研究

Abstract

1) The amount of urinary 17-KS was clinically investigated on the patients with various urogenital diseases. 2) Administratio n of various hormones to the patients undergone bilatral orchiectomy, led the auther to the conclusion that estrogene therapy caused a decrease in urinary 17-KS excretion, while the other therapy caused an increase in the excretion. 3) The rate of 17-KS excretion after the transplantation of cow's endocrine organs, was generally apt to increase. 4) In the patients with prostatic hypertrophy and prostatic cancer, the average rate of urinary 17-KS excretion was within the normal range. The patients with prostatic cancer excreted much more amount of 17-KS into the urine that of prostatic hypertrophy. Most diseases of the bladder did not affect the rate of urinary 17-KS excretion except that of vesical cancer which decreased the rate of excretion more than vesical benign tumor. Hypernephroma especially, caused remarkably high level of the urinary excretion of 17-KS. 5) In most patients with renal tuberculosis, the rate of urinary 17-KS excretion were within or below the normal range. Unilateral or bilateral epididymectomy for tuberculosis generally produced no significance in the rate of urinary 17-KS excretion except for the aged patients whose rate of excretion was relatively low. 6) The rate of urinary 17-KS excretion in the ca s e of sexual dysfunction was within the normal range.